J M Olivares

Summary

Publications

  1. ncbi request reprint Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain
    Jose M Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Appl Health Econ Health Policy 6:41-53. 2008
  2. doi request reprint Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry
    J M Olivares
    Servicio de Psiquiatria, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Curr Med Res Opin 25:2197-206. 2009
  3. pmc Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
    Marina de Salas-Cansado
    Trial Form Support Spain, Madrid
    Clinicoecon Outcomes Res 4:157-68. 2012
  4. pmc Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa
    Jose Manuel Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Patient Prefer Adherence 7:121-32. 2013
  5. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
  6. doi request reprint Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)
    J M Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo Spain
    Eur Psychiatry 24:287-96. 2009
  7. ncbi request reprint Validation of the Spanish version of the Social Functioning Scale
    A Torres
    Psychiatry Service, Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain
    Actas Esp Psiquiatr 33:216-20. 2005

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain
    Jose M Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Appl Health Econ Health Policy 6:41-53. 2008
    ..The availability of long-acting injectable risperidone may increase adherence to antipsychotic treatment and lead to improved clinical and economic outcomes for patients with schizophrenia...
  2. doi request reprint Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry
    J M Olivares
    Servicio de Psiquiatria, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Curr Med Res Opin 25:2197-206. 2009
    ..Risperidone long-acting injection (RLAI) has been shown to be efficacious, improve compliance, and increase long-term retention rate on therapy...
  3. pmc Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
    Marina de Salas-Cansado
    Trial Form Support Spain, Madrid
    Clinicoecon Outcomes Res 4:157-68. 2012
    ....
  4. pmc Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa
    Jose Manuel Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
    Patient Prefer Adherence 7:121-32. 2013
    ..Understanding psychiatrists' perception of the causes and consequences of nonadherence is crucial to addressing adherence problems effectively...
  5. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
    ..abstract:..
  6. doi request reprint Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)
    J M Olivares
    Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo Spain
    Eur Psychiatry 24:287-96. 2009
    ..The electronic Schizophrenia Treatment Adherence Registry (e-STAR) is a prospective, observational study of patients with schizophrenia designed to evaluate long-term treatment outcomes in routine clinical practice...
  7. ncbi request reprint Validation of the Spanish version of the Social Functioning Scale
    A Torres
    Psychiatry Service, Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain
    Actas Esp Psiquiatr 33:216-20. 2005
    ..The Social Functioning Scale (SFS) may be a good instrument to evaluate different therapeutical strategies for the rehabilitation of the schizophrenic patient. The aim of this paper is to validate the Spanish version of the SFS...